Screener
TG Therapeutics TGTX Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherSellingGeneralAndAdministrativeExpense.
The source filing: TG Therapeutics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001437749-26-025955
FAQ
- What is TG Therapeutics's other operating expenses?
- TG Therapeutics (TGTX) reported other operating expenses of $62.33M in Q2 2026.
- How has TG Therapeutics's other operating expenses changed year-over-year?
- TG Therapeutics's other operating expenses increased by 43.1% year-over-year, from $43.54M to $62.33M.
- What is the long-term trend for TG Therapeutics's other operating expenses?
- Over 4 years (2021 to 2025), TG Therapeutics's other operating expenses has grown at a -14.9% compound annual growth rate (CAGR), from $351.46M to $183.98M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.
Ask your AI about TG Therapeutics's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude